Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
893.40    9.40 (1.06%)
Bid:
895.40
Ask:
895.80
Spread: 0.40 (0.045%)
Market Cap: £11.19b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

Divestment of Maritime Intelligence

4 Aug 2022 07:00

RNS Number : 8634U
Informa PLC
04 August 2022
 

Informa PLC Press Release

4 August 2022

 

Divestment of Maritime Intelligence (Lloyd's List) completes £2.5bn ($3bn) GAP II Portfolio Focus Programme

Group Prioritises Leadership Businesses in Academic Markets and B2B Markets

Informa (LSE: INF.L), the international Academic Markets, B2B Markets and Digital Services Group, today announces the completion of its Portfolio Focus programme following the divestment of Maritime Intelligence (Lloyd's List) for £385m ($458m); Total value realised through theGroup's 2021-2024 Growth Acceleration Plan (GAP II) is c.£2.5bn (c.$3bn).

Stephen A. Carter, Group Chief Executive, Informa PLC, said:

"Over the past year, we have streamlined and refocused the Group to concentrate on our leadership positions in Academic Markets and B2B Markets. By divesting non-core assets, including today's sale of Maritime Intelligence, we have generated $3bn in value, providing additional flexibility for shareholder returns, additional growth investment and further targeted expansion."

Completion of the GAP II Portfolio Focus programme coincides with the publication of Informa's first half results, which showed statutory H1 revenues1 rising by 59.1% to £1,096.3m and Adjusted Operating Profit1 increasing by 227% to £234.5m (2021: £71.8m). For more details, visit www.informa.com

GAP II: Completion of Portfolio Focus

The GAP II programme sees Informa reinforce its position as a leading player in both Academic Markets and B2B Markets.

As part of GAP II, Informa has:

· Generated c.£2.5bn (c$3bn) of total value through the divestment of its Intelligence portfolio, at a blended 2021 EV/EBITDA multiple of 28x;

· Divested of Pharma Intelligence (Citeline) at a valuation of £1.9bn (c.$2.3bn) to Warburg Pincus, retaining a 15% equity interest;

· Divested of Maritime Intelligence (Lloyd's List), at a valuation of £385m (c.$458m) to Montagu, receiving cash proceeds (subject to finalisation of working capital and capital structure) whilst retaining a 20% equity interest;

· Divested of Fund Flow Intelligence (EPFR) at a valuation of £162m (c.$193m) to Montagu;

· Expanded in B2B Digital Services with the acquisition of Industry Dive, a leader in specialist digital content and audience development for £327m ($389m), augmenting our digital services capabilities and delivering further content-led services to specialist B2B markets;

· Invested for Growth: Initiated the GAP II investment programme initially focusing on strengthening Open Research platforms in Academic Markets, the continuing roll-out of IIRIS (First Party Data) across the B2B portfolio, and enhancing the quality and range of smart event services;

· Expanded by Market, increasing Informa's presence in the growing Beauty & Personal Care B2B market by extending a partnership with BolognaFiere into 5+ new geographies, including Mainland China, the Middle East and the US;

· Expanded Geographically in the Middle East through a new partnership agreement to bring additional Live & On-Demand B2B Events to Saudi Arabia, following the success of the landmark Tech event, LEAP.

Chief Executive Stephen A. Carter concluded:

"We have come through a period of unprecedented volatility due to COVID-19 as a stronger Group that is positioned for growth in the global Knowledge Economy. We have refocused our portfolio on Academic Markets and B2B Markets - where we Champion the Specialist - whilst securing highly attractive valuations for our portfolio of non-core Intelligence businesses.

"Despite the wider macro-economic uncertainties, we remain confident of delivering our guidance for the current year, alongside delivering accelerated returns to shareholders through a £725m share buyback and the resumption of ordinary dividends."

 

Enquiries

Stephen A. Carter, Group Chief Executive

+44 (0) 20 8052 0400

Gareth Wright, Group Finance Director

+44 (0) 20 8052 0400

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 8052 2787

Tim Burt / Simon Duke, Teneo

+44 (0) 7583 413254 / +44 (0) 7815 779225

1 Continuing and Discontinued operations

About Maritime Intelligence

Maritime Intelligence is at the heart of global seaborne transport and trade, providing the information needed by professionals at the right time and in the right format, to help them make better decisions, more quickly. Under the brand Lloyd's List Intelligence, it provides business critical real-time data, insights and analytics that help power global shipping operations and risk and compliance management

In 2021, Maritime Intelligence accounted for approximately 12% of Informa Intelligence's divisional revenues of £348.3m and around 15% of adjusted operating profit of £109.8m. Reported revenues were £43m and statutory profit before tax was £15m for 2021. Gross assets were £103.3m as at 30 June 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISGGGDIDGGDGDS
Date   Source Headline
9th Jul 20267:00 amRNSAppointment of Informa PLC Chair-Elect
6th Jul 20267:00 amRNSTransaction in Own Shares
1st Jul 202610:00 amRNSTotal Voting Rights
29th Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 20267:00 amRNSTransaction in Own Shares
18th Jun 20263:23 pmRNSResult of AGM
18th Jun 20267:00 amRNSTrading Update
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 202612:14 pmRNSHolding(s) in Company
1st Jun 202610:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20262:52 pmRNSHolding(s) in Company
22nd May 20269:40 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSAnnual Financial Report and Notice of 2026 AGM
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSAppointment of inD CEO
15th Apr 20263:30 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:01 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
9th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:11 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 202612:32 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.